This paper discusses the problem of reflecting the impact of new and improvedmedical treatments including preventative public health measures in measures ofhealth services gross output and in the pric
*Average cost (heath system perspective) for maternal health provision in West Africa Francs. **Institutional delivery. ***(Ratio of incremental cost to incremental effect). Summary estimates are pres
Notes: CHB = chronic hepatitis B;HCC = hepatocellular carcinoma; DALY = disability-adjusted life year; *: Cost for preventing one patient with HCC, 10 patients with cirrhosis, and 100 patients wit
QALY = quality-adjusted life year; ICER = incremental cost-effectiveness ratio; base = cheapest alternative; dom = dominated. Results are shown as means and 95% credibility intervals.
